25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Boston Scientific Corporation
Buy, Hold or Sell?

Let's analyze Boston Scientific Corporation together

I guess you are interested in Boston Scientific Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Boston Scientific Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Boston Scientific Corporation

I send you an email if I find something interesting about Boston Scientific Corporation.

1. Quick Overview

1.1. Quick analysis of Boston Scientific Corporation (30 sec.)










1.2. What can you expect buying and holding a share of Boston Scientific Corporation? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
46.9%

What is your share worth?

Current worth
€13.56
Expected worth in 1 year
€14.75
How sure are you?
84.4%

+ What do you gain per year?

Total Gains per Share
€1.18
Return On Investment
1.2%

For what price can you sell your share?

Current Price per Share
€95.00
Expected price per share
€84.00 - €
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Boston Scientific Corporation (5 min.)




Live pricePrice per Share (EOD)
€95.00
Intrinsic Value Per Share
€17.60 - €20.81
Total Value Per Share
€31.17 - €34.37

2.2. Growth of Boston Scientific Corporation (5 min.)




Is Boston Scientific Corporation growing?

Current yearPrevious yearGrowGrow %
How rich?$20.9b$18.3b$1.9b9.8%

How much money is Boston Scientific Corporation making?

Current yearPrevious yearGrowGrow %
Making money$447.4m$307.1m$140.3m31.4%
Net Profit Margin11.3%8.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Boston Scientific Corporation (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#4 / 309

Most Revenue
#10 / 309

Most Profit
#9 / 309
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Boston Scientific Corporation?

Welcome investor! Boston Scientific Corporation's management wants to use your money to grow the business. In return you get a share of Boston Scientific Corporation.

First you should know what it really means to hold a share of Boston Scientific Corporation. And how you can make/lose money.

Speculation

The Price per Share of Boston Scientific Corporation is €95.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Boston Scientific Corporation.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Boston Scientific Corporation, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €13.56. Based on the TTM, the Book Value Change Per Share is €0.30 per quarter. Based on the YOY, the Book Value Change Per Share is €0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Boston Scientific Corporation.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.320.3%0.300.3%0.280.3%0.300.3%0.240.3%
Usd Book Value Change Per Share0.240.2%0.310.3%0.250.3%0.380.4%0.440.5%
Usd Dividend Per Share0.000.0%0.000.0%0.010.0%0.010.0%0.000.0%
Usd Total Gains Per Share0.240.2%0.310.3%0.260.3%0.390.4%0.450.5%
Usd Price Per Share77.62-68.71-49.44-45.76-39.53-
Price to Earnings Ratio61.08-59.35-60.84-102.15-80.21-
Price-to-Total Gains Ratio329.49-234.36--199.96--28.80-79.91-
Price to Book Ratio5.46-4.97-3.97-3.84-4.40-
Price-to-Total Gains Ratio329.49-234.36--199.96--28.80-79.91-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share99.6455
Number of shares10
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.310.38
Usd Total Gains Per Share0.310.39
Gains per Quarter (10 shares)3.103.90
Gains per Year (10 shares)12.4015.58
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101220156
20251413122
30372614638
40503816154
50625017670
60746229286
7087742107102
8099862122118
90112983138134
1001241103153150

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%18.02.00.090.0%29.03.00.090.6%29.03.00.090.6%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%16.04.00.080.0%27.05.00.084.4%27.05.00.084.4%
Dividend per Share0.00.04.00.0%7.00.05.058.3%15.00.05.075.0%15.00.017.046.9%15.00.017.046.9%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%16.04.00.080.0%27.05.00.084.4%27.05.00.084.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Boston Scientific Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2250.296-24%0.241-7%0.364-38%0.424-47%
Book Value Per Share--13.56313.149+3%11.860+14%11.168+21%8.917+52%
Current Ratio--1.4821.520-2%1.406+5%1.493-1%1.275+16%
Debt To Asset Ratio--0.4500.447+1%0.449+0%0.475-5%0.527-15%
Debt To Equity Ratio--0.8270.819+1%0.824+0%0.916-10%1.166-29%
Dividend Per Share----0%0.007-100%0.007-100%0.004-100%
Enterprise Value--92730745384.00080876119548.160+15%55228031741.640+68%49482009595.528+87%41776453508.051+122%
Eps--0.3030.289+5%0.265+14%0.285+6%0.231+31%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--5.7745.301+9%4.203+37%3.952+46%3.641+59%
Free Cash Flow Per Share--0.4740.321+48%0.275+72%0.224+112%0.224+112%
Free Cash Flow To Equity Per Share--0.4780.595-20%0.273+75%0.269+78%0.269+78%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--20.809--------
Intrinsic Value_10Y_min--17.603--------
Intrinsic Value_1Y_max--1.083--------
Intrinsic Value_1Y_min--1.063--------
Intrinsic Value_3Y_max--4.018--------
Intrinsic Value_3Y_min--3.820--------
Intrinsic Value_5Y_max--7.874--------
Intrinsic Value_5Y_min--7.242--------
Market Cap140013851520.000+22%109063421184.00096550604348.160+13%69467135516.640+57%64298413650.528+70%55549666561.176+96%
Net Profit Margin--0.1110.113-2%0.088+26%0.133-17%0.117-5%
Operating Margin----0%0.169-100%0.124-100%0.142-100%
Operating Ratio--1.1411.133+1%1.140+0%1.175-3%1.137+0%
Pb Ratio7.004+22%5.4564.968+10%3.971+37%3.843+42%4.400+24%
Pe Ratio78.408+22%61.07659.346+3%60.839+0%102.146-40%80.205-24%
Price Per Share95.000+22%74.00065.510+13%47.134+57%43.627+70%37.691+96%
Price To Free Cash Flow Ratio50.148+22%39.063-44.225+213%87.226-55%21.765+79%13.603+187%
Price To Total Gains Ratio422.998+22%329.493234.361+41%-199.960+161%-28.802+109%79.906+312%
Quick Ratio--0.4230.443-5%0.488-13%0.455-7%0.415+2%
Return On Assets--0.0120.012+1%0.009+34%0.013-7%0.012+1%
Return On Equity--0.0230.022+1%0.017+35%0.027-16%0.027-15%
Total Gains Per Share--0.2250.296-24%0.248-9%0.371-40%0.428-48%
Usd Book Value--20967435898.76020326836507.933+3%18333999590.040+14%17265266689.904+21%13785143587.739+52%
Usd Book Value Change Per Share--0.2360.310-24%0.253-7%0.382-38%0.445-47%
Usd Book Value Per Share--14.22613.792+3%12.440+14%11.715+21%9.353+52%
Usd Dividend Per Share----0%0.007-100%0.007-100%0.005-100%
Usd Enterprise Value--97265278833.27884830961794.065+15%57928682493.806+68%51901679864.749+87%43819322084.595+122%
Usd Eps--0.3180.304+5%0.278+14%0.299+6%0.242+31%
Usd Free Cash Flow--732132200.000496129700.000+48%424804500.000+72%328672815.000+123%205420509.375+256%
Usd Free Cash Flow Per Share--0.4970.337+48%0.288+72%0.235+112%0.235+112%
Usd Free Cash Flow To Equity Per Share--0.5020.624-20%0.287+75%0.282+78%0.282+78%
Usd Market Cap146860528859.328+22%114396622479.898101271928900.785+13%72864078443.404+57%67442606078.039+70%58266045256.018+96%
Usd Price Per Share99.646+22%77.61968.713+13%49.439+57%45.760+70%39.534+96%
Usd Profit--468255392.280447494068.798+5%307167532.970+52%426732745.315+10%348096105.920+35%
Usd Revenue--4211296893.3903979670561.525+6%3441126833.118+22%3192391169.612+32%2898612188.923+45%
Usd Total Gains Per Share--0.2360.310-24%0.260-9%0.390-40%0.449-48%
 EOD+4 -4MRQTTM+19 -16YOY+24 -145Y+23 -1510Y+25 -13

3.3 Fundamental Score

Let's check the fundamental score of Boston Scientific Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1578.408
Price to Book Ratio (EOD)Between0-17.004
Net Profit Margin (MRQ)Greater than00.111
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.423
Current Ratio (MRQ)Greater than11.482
Debt to Asset Ratio (MRQ)Less than10.450
Debt to Equity Ratio (MRQ)Less than10.827
Return on Equity (MRQ)Greater than0.150.023
Return on Assets (MRQ)Greater than0.050.012
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Boston Scientific Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose98.000
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Fundamental data was last updated by Penke on 2025-01-12 03:10:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Boston Scientific Corporation earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Boston Scientific Corporation to the Medical Devices industry mean.
  • A Net Profit Margin of 11.1% means that €0.11 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Boston Scientific Corporation:

  • The MRQ is 11.1%. The company is making a huge profit. +2
  • The TTM is 11.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.1%TTM11.3%-0.2%
TTM11.3%YOY8.8%+2.5%
TTM11.3%5Y13.3%-2.0%
5Y13.3%10Y11.7%+1.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ11.1%-6.6%+17.7%
TTM11.3%-14.6%+25.9%
YOY8.8%-15.0%+23.8%
5Y13.3%-15.7%+29.0%
10Y11.7%-14.9%+26.6%
4.3.1.2. Return on Assets

Shows how efficient Boston Scientific Corporation is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Boston Scientific Corporation to the Medical Devices industry mean.
  • 1.2% Return on Assets means that Boston Scientific Corporation generated €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Boston Scientific Corporation:

  • The MRQ is 1.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.2%TTM1.2%+0.0%
TTM1.2%YOY0.9%+0.3%
TTM1.2%5Y1.3%-0.1%
5Y1.3%10Y1.2%+0.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2%-2.3%+3.5%
TTM1.2%-3.4%+4.6%
YOY0.9%-4.0%+4.9%
5Y1.3%-2.8%+4.1%
10Y1.2%-3.4%+4.6%
4.3.1.3. Return on Equity

Shows how efficient Boston Scientific Corporation is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Boston Scientific Corporation to the Medical Devices industry mean.
  • 2.3% Return on Equity means Boston Scientific Corporation generated €0.02 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Boston Scientific Corporation:

  • The MRQ is 2.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.3%TTM2.2%+0.0%
TTM2.2%YOY1.7%+0.6%
TTM2.2%5Y2.7%-0.4%
5Y2.7%10Y2.7%+0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%-2.9%+5.2%
TTM2.2%-4.0%+6.2%
YOY1.7%-4.5%+6.2%
5Y2.7%-4.1%+6.8%
10Y2.7%-5.7%+8.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Boston Scientific Corporation.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Boston Scientific Corporation is operating .

  • Measures how much profit Boston Scientific Corporation makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Boston Scientific Corporation to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Boston Scientific Corporation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY16.9%-16.9%
TTM-5Y12.4%-12.4%
5Y12.4%10Y14.2%-1.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.5%+13.5%
TTM--21.7%+21.7%
YOY16.9%-13.5%+30.4%
5Y12.4%-16.6%+29.0%
10Y14.2%-14.9%+29.1%
4.3.2.2. Operating Ratio

Measures how efficient Boston Scientific Corporation is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.14 means that the operating costs are €1.14 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Boston Scientific Corporation:

  • The MRQ is 1.141. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.133. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.141TTM1.133+0.008
TTM1.133YOY1.140-0.007
TTM1.1335Y1.175-0.043
5Y1.17510Y1.137+0.038
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1411.239-0.098
TTM1.1331.297-0.164
YOY1.1401.321-0.181
5Y1.1751.366-0.191
10Y1.1371.311-0.174
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Boston Scientific Corporation.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Boston Scientific Corporation is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.48 means the company has €1.48 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Boston Scientific Corporation:

  • The MRQ is 1.482. The company is just able to pay all its short-term debts.
  • The TTM is 1.520. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.482TTM1.520-0.038
TTM1.520YOY1.406+0.115
TTM1.5205Y1.493+0.027
5Y1.49310Y1.275+0.218
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4822.591-1.109
TTM1.5202.705-1.185
YOY1.4062.928-1.522
5Y1.4933.459-1.966
10Y1.2753.527-2.252
4.4.3.2. Quick Ratio

Measures if Boston Scientific Corporation is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Boston Scientific Corporation to the Medical Devices industry mean.
  • A Quick Ratio of 0.42 means the company can pay off €0.42 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Boston Scientific Corporation:

  • The MRQ is 0.423. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.443. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.423TTM0.443-0.020
TTM0.443YOY0.488-0.045
TTM0.4435Y0.455-0.012
5Y0.45510Y0.415+0.040
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4231.474-1.051
TTM0.4431.598-1.155
YOY0.4881.899-1.411
5Y0.4552.415-1.960
10Y0.4152.557-2.142
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Boston Scientific Corporation.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Boston Scientific Corporation assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Boston Scientific Corporation to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.45 means that Boston Scientific Corporation assets are financed with 45.0% credit (debt) and the remaining percentage (100% - 45.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Boston Scientific Corporation:

  • The MRQ is 0.450. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.447. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.450TTM0.447+0.003
TTM0.447YOY0.449-0.002
TTM0.4475Y0.475-0.028
5Y0.47510Y0.527-0.051
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4500.409+0.041
TTM0.4470.406+0.041
YOY0.4490.359+0.090
5Y0.4750.429+0.046
10Y0.5270.451+0.076
4.5.4.2. Debt to Equity Ratio

Measures if Boston Scientific Corporation is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Boston Scientific Corporation to the Medical Devices industry mean.
  • A Debt to Equity ratio of 82.7% means that company has €0.83 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Boston Scientific Corporation:

  • The MRQ is 0.827. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.819. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.827TTM0.819+0.008
TTM0.819YOY0.824-0.005
TTM0.8195Y0.916-0.098
5Y0.91610Y1.166-0.250
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8270.591+0.236
TTM0.8190.619+0.200
YOY0.8240.523+0.301
5Y0.9160.644+0.272
10Y1.1660.721+0.445
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Boston Scientific Corporation generates.

  • Above 15 is considered overpriced but always compare Boston Scientific Corporation to the Medical Devices industry mean.
  • A PE ratio of 61.08 means the investor is paying €61.08 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Boston Scientific Corporation:

  • The EOD is 78.408. Based on the earnings, the company is expensive. -2
  • The MRQ is 61.076. Based on the earnings, the company is expensive. -2
  • The TTM is 59.346. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD78.408MRQ61.076+17.332
MRQ61.076TTM59.346+1.730
TTM59.346YOY60.839-1.494
TTM59.3465Y102.146-42.800
5Y102.14610Y80.205+21.940
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD78.408-1.442+79.850
MRQ61.076-1.755+62.831
TTM59.346-1.945+61.291
YOY60.839-2.854+63.693
5Y102.146-2.445+104.591
10Y80.205-2.137+82.342
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Boston Scientific Corporation:

  • The EOD is 50.148. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 39.063. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is -44.225. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD50.148MRQ39.063+11.085
MRQ39.063TTM-44.225+83.288
TTM-44.225YOY87.226-131.450
TTM-44.2255Y21.765-65.990
5Y21.76510Y13.603+8.162
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD50.148-1.573+51.721
MRQ39.063-2.004+41.067
TTM-44.225-2.233-41.992
YOY87.226-5.154+92.380
5Y21.765-3.086+24.851
10Y13.603-3.932+17.535
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Boston Scientific Corporation is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 5.46 means the investor is paying €5.46 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Boston Scientific Corporation:

  • The EOD is 7.004. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.456. Based on the equity, the company is overpriced. -1
  • The TTM is 4.968. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD7.004MRQ5.456+1.548
MRQ5.456TTM4.968+0.488
TTM4.968YOY3.971+0.997
TTM4.9685Y3.843+1.124
5Y3.84310Y4.400-0.557
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD7.0042.105+4.899
MRQ5.4562.275+3.181
TTM4.9682.416+2.552
YOY3.9712.909+1.062
5Y3.8434.275-0.432
10Y4.4004.759-0.359
4.6.2. Total Gains per Share

2.4. Latest News of Boston Scientific Corporation

Does Boston Scientific Corporation still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Boston Scientific Corporation to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-01-28
00:00
Boston Scientific (BSX) Increases Despite Market Slip: Here's What You Need to KnowRead
2025-01-27
13:49
Is Boston Scientific (BSX) Among the Best Fundamental Stocks to Buy Now?Read
2025-01-25
14:00
Boston Scientific's (NYSE:BSX) five-year earnings growth trails the solid shareholder returnsRead
2025-01-24
18:03
Boston Scientific Corp (BSX): AI-Driven Innovation and Barclays’ Bullish $111 Price TargetRead
2025-01-19
15:00
Boston Scientific Corporation (NYSE:BSX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?Read
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets38,078,000
Total Liabilities17,122,000
Total Stockholder Equity20,708,000
 As reported
Total Liabilities 17,122,000
Total Stockholder Equity+ 20,708,000
Total Assets = 38,078,000

Assets

Total Assets38,078,000
Total Current Assets8,761,000
Long-term Assets29,319,000
Total Current Assets
Cash And Cash Equivalents 2,502,000
Net Receivables 2,501,000
Inventory 2,753,000
Other Current Assets 435,000
Total Current Assets  (as reported)8,761,000
Total Current Assets  (calculated)8,191,000
+/- 570,000
Long-term Assets
Property Plant Equipment 3,498,000
Goodwill 15,033,000
Long Term Investments 532,000
Intangible Assets 5,755,000
Long-term Assets Other 665,000
Long-term Assets  (as reported)29,319,000
Long-term Assets  (calculated)25,483,000
+/- 3,836,000

Liabilities & Shareholders' Equity

Total Current Liabilities5,910,000
Long-term Liabilities11,212,000
Total Stockholder Equity20,708,000
Total Current Liabilities
Short Long Term Debt 1,652,000
Accounts payable 907,000
Other Current Liabilities 315,000
Total Current Liabilities  (as reported)5,910,000
Total Current Liabilities  (calculated)2,874,000
+/- 3,036,000
Long-term Liabilities
Long term Debt 9,229,000
Capital Lease Obligations Min Short Term Debt377,000
Long-term Liabilities Other 652,000
Long-term Liabilities  (as reported)11,212,000
Long-term Liabilities  (calculated)10,258,000
+/- 954,000
Total Stockholder Equity
Retained Earnings 2,107,000
Total Stockholder Equity (as reported)20,708,000
Total Stockholder Equity (calculated)2,107,000
+/- 18,601,000
Other
Capital Stock17,000
Common Stock Shares Outstanding 1,473,442
Net Debt 8,379,000
Net Invested Capital 31,589,000
Net Working Capital 2,851,000
Property Plant and Equipment Gross 7,120,000



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
18,096,000
17,943,000
18,382,000
18,636,000
19,042,000
19,202,000
19,615,000
20,379,000
20,999,000
23,802,000
24,309,000
26,756,000
30,565,000
30,113,000
30,823,000
30,845,000
30,777,000
30,900,000
31,168,000
31,877,000
32,229,000
32,337,000
32,189,000
31,947,000
32,469,000
32,892,000
33,601,000
34,043,000
35,136,000
36,669,000
37,108,000
38,078,000
38,078,00037,108,00036,669,00035,136,00034,043,00033,601,00032,892,00032,469,00031,947,00032,189,00032,337,00032,229,00031,877,00031,168,00030,900,00030,777,00030,845,00030,823,00030,113,00030,565,00026,756,00024,309,00023,802,00020,999,00020,379,00019,615,00019,202,00019,042,00018,636,00018,382,00017,943,00018,096,000
   > Total Current Assets 
3,239,000
3,026,000
3,222,000
3,478,000
3,822,000
4,080,000
3,929,000
3,970,000
4,002,000
6,234,000
6,334,000
4,847,000
4,699,000
4,823,000
5,803,000
6,160,000
6,694,000
6,101,000
6,758,000
6,229,000
6,317,000
5,065,000
5,083,000
5,144,000
5,760,000
5,704,000
5,886,000
6,504,000
6,514,000
8,185,000
8,991,000
8,761,000
8,761,0008,991,0008,185,0006,514,0006,504,0005,886,0005,704,0005,760,0005,144,0005,083,0005,065,0006,317,0006,229,0006,758,0006,101,0006,694,0006,160,0005,803,0004,823,0004,699,0004,847,0006,334,0006,234,0004,002,0003,970,0003,929,0004,080,0003,822,0003,478,0003,222,0003,026,0003,239,000
       Cash And Cash Equivalents 
196,000
156,000
195,000
210,000
188,000
287,000
208,000
168,000
146,000
139,000
123,000
277,000
217,000
370,000
1,724,000
2,022,000
1,734,000
2,016,000
2,675,000
1,947,000
1,925,000
325,000
276,000
338,000
928,000
570,000
426,000
952,000
865,000
2,329,000
2,913,000
2,502,000
2,502,0002,913,0002,329,000865,000952,000426,000570,000928,000338,000276,000325,0001,925,0001,947,0002,675,0002,016,0001,734,0002,022,0001,724,000370,000217,000277,000123,000139,000146,000168,000208,000287,000188,000210,000195,000156,000196,000
       Net Receivables 
1,547,000
1,494,000
1,444,000
1,470,000
1,548,000
1,580,000
1,587,000
1,580,000
1,608,000
1,621,000
1,712,000
1,796,000
1,933,000
1,702,000
1,457,000
1,598,000
1,531,000
1,631,000
1,675,000
1,669,000
1,778,000
1,866,000
1,917,000
1,871,000
1,970,000
2,076,000
2,134,000
2,101,000
2,228,000
2,304,000
2,400,000
2,501,000
2,501,0002,400,0002,304,0002,228,0002,101,0002,134,0002,076,0001,970,0001,871,0001,917,0001,866,0001,778,0001,669,0001,675,0001,631,0001,531,0001,598,0001,457,0001,702,0001,933,0001,796,0001,712,0001,621,0001,608,0001,580,0001,587,0001,580,0001,548,0001,470,0001,444,0001,494,0001,547,000
       Inventory 
955,000
971,000
1,023,000
1,077,000
1,078,000
1,113,000
1,087,000
1,134,000
1,166,000
1,228,000
1,300,000
1,566,000
1,579,000
1,628,000
1,516,000
1,472,000
1,351,000
1,407,000
1,430,000
1,603,000
1,610,000
1,736,000
1,752,000
1,788,000
1,867,000
2,050,000
2,250,000
2,404,000
2,484,000
2,561,000
2,608,000
2,753,000
2,753,0002,608,0002,561,0002,484,0002,404,0002,250,0002,050,0001,867,0001,788,0001,752,0001,736,0001,610,0001,603,0001,430,0001,407,0001,351,0001,472,0001,516,0001,628,0001,579,0001,566,0001,300,0001,228,0001,166,0001,134,0001,087,0001,113,0001,078,0001,077,0001,023,000971,000955,000
       Other Current Assets 
541,000
405,000
469,000
649,000
1,008,000
1,100,000
1,047,000
1,088,000
1,082,000
3,083,000
3,024,000
1,019,000
970,000
1,123,000
1,106,000
1,068,000
2,078,000
1,047,000
978,000
1,010,000
1,004,000
1,138,000
1,138,000
1,147,000
995,000
1,008,000
1,076,000
1,047,000
333,000
402,000
413,000
435,000
435,000413,000402,000333,0001,047,0001,076,0001,008,000995,0001,147,0001,138,0001,138,0001,004,0001,010,000978,0001,047,0002,078,0001,068,0001,106,0001,123,000970,0001,019,0003,024,0003,083,0001,082,0001,088,0001,047,0001,100,0001,008,000649,000469,000405,000541,000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
17,567,000
17,974,000
21,911,000
25,866,000
25,291,000
25,022,000
24,684,000
24,081,000
24,799,000
24,409,000
25,648,000
25,911,000
27,274,000
27,104,000
26,805,000
26,710,000
27,190,000
27,716,000
27,539,000
28,621,000
28,483,000
28,117,000
29,319,000
29,319,00028,117,00028,483,00028,621,00027,539,00027,716,00027,190,00026,710,00026,805,00027,104,00027,274,00025,911,00025,648,00024,409,00024,799,00024,081,00024,684,00025,022,00025,291,00025,866,00021,911,00017,974,00017,567,000000000000
       Property Plant Equipment 
1,630,000
1,652,000
1,651,000
1,678,000
1,697,000
1,700,000
1,715,000
1,730,000
1,782,000
2,039,000
2,072,000
2,248,000
2,415,000
2,425,000
2,396,000
2,375,000
2,542,000
2,460,000
2,493,000
2,525,000
2,687,000
2,689,000
2,646,000
2,661,000
2,831,000
2,878,000
2,979,000
3,082,000
3,298,000
3,327,000
3,366,000
3,498,000
3,498,0003,366,0003,327,0003,298,0003,082,0002,979,0002,878,0002,831,0002,661,0002,646,0002,689,0002,687,0002,525,0002,493,0002,460,0002,542,0002,375,0002,396,0002,425,0002,415,0002,248,0002,072,0002,039,0001,782,0001,730,0001,715,0001,700,0001,697,0001,678,0001,651,0001,652,0001,630,000
       Goodwill 
6,678,000
6,680,000
6,871,000
6,882,000
6,998,000
6,984,000
7,242,000
7,588,000
7,911,000
8,179,000
8,451,000
10,015,000
10,176,000
10,098,000
10,101,000
10,137,000
9,951,000
10,868,000
10,874,000
11,820,000
11,988,000
12,949,000
12,883,000
12,852,000
12,920,000
13,269,000
13,659,000
13,608,000
14,387,000
14,361,000
14,397,000
15,033,000
15,033,00014,397,00014,361,00014,387,00013,608,00013,659,00013,269,00012,920,00012,852,00012,883,00012,949,00011,988,00011,820,00010,874,00010,868,0009,951,00010,137,00010,101,00010,098,00010,176,00010,015,0008,451,0008,179,0007,911,0007,588,0007,242,0006,984,0006,998,0006,882,0006,871,0006,680,0006,678,000
       Long Term Investments 
0
0
324,000
349,000
352,000
443,000
382,000
384,000
423,000
343,000
416,000
466,000
458,000
437,000
467,000
567,000
918,000
643,000
616,000
434,000
412,000
406,000
376,000
381,000
407,000
385,000
421,000
427,000
413,000
429,000
450,000
532,000
532,000450,000429,000413,000427,000421,000385,000407,000381,000376,000406,000412,000434,000616,000643,000918,000567,000467,000437,000458,000466,000416,000343,000423,000384,000382,000443,000352,000349,000324,00000
       Intangible Assets 
5,883,000
5,743,000
5,921,000
5,783,000
5,837,000
5,713,000
5,934,000
6,297,000
6,372,000
6,448,000
6,486,000
8,075,000
7,886,000
7,394,000
7,161,000
6,797,000
5,916,000
5,991,000
5,787,000
6,227,000
6,120,000
6,582,000
6,349,000
6,059,000
5,903,000
6,061,000
6,064,000
5,850,000
6,003,000
5,837,000
5,417,000
5,755,000
5,755,0005,417,0005,837,0006,003,0005,850,0006,064,0006,061,0005,903,0006,059,0006,349,0006,582,0006,120,0006,227,0005,787,0005,991,0005,916,0006,797,0007,161,0007,394,0007,886,0008,075,0006,486,0006,448,0006,372,0006,297,0005,934,0005,713,0005,837,0005,783,0005,921,0005,743,0005,883,000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
1,158,000
1,217,000
1,879,000
519,000
483,000
476,000
457,000
436,000
455,000
447,000
418,000
394,000
390,000
531,000
541,000
558,000
564,000
572,000
577,000
572,000
612,000
640,000
665,000
665,000640,000612,000572,000577,000572,000564,000558,000541,000531,000390,000394,000418,000447,000455,000436,000457,000476,000483,000519,0001,879,0001,217,0001,158,000000000000
> Total Liabilities 
11,363,000
10,890,000
11,147,000
11,048,000
12,030,000
12,172,000
11,871,000
12,090,000
12,273,000
14,569,000
14,884,000
17,057,000
16,688,000
16,309,000
15,207,000
15,281,000
15,451,000
15,181,000
15,226,000
15,415,000
15,607,000
15,602,000
14,938,000
14,307,000
14,896,000
14,783,000
15,116,000
14,914,000
15,606,000
16,501,000
16,499,000
17,122,000
17,122,00016,499,00016,501,00015,606,00014,914,00015,116,00014,783,00014,896,00014,307,00014,938,00015,602,00015,607,00015,415,00015,226,00015,181,00015,451,00015,281,00015,207,00016,309,00016,688,00017,057,00014,884,00014,569,00012,273,00012,090,00011,871,00012,172,00012,030,00011,048,00011,147,00010,890,00011,363,000
   > Total Current Liabilities 
3,587,000
3,490,000
4,300,000
4,828,000
5,654,000
4,988,000
4,753,000
5,082,000
5,260,000
4,479,000
4,850,000
4,254,000
4,866,000
3,976,000
3,108,000
3,302,000
3,681,000
3,393,000
4,073,000
4,022,000
4,274,000
4,275,000
3,883,000
3,549,000
3,803,000
4,083,000
4,562,000
4,579,000
4,933,000
4,916,000
5,576,000
5,910,000
5,910,0005,576,0004,916,0004,933,0004,579,0004,562,0004,083,0003,803,0003,549,0003,883,0004,275,0004,274,0004,022,0004,073,0003,393,0003,681,0003,302,0003,108,0003,976,0004,866,0004,254,0004,850,0004,479,0005,260,0005,082,0004,753,0004,988,0005,654,0004,828,0004,300,0003,490,0003,587,000
       Short-term Debt 
64,000
5,000
5,835,000
1,266,000
1,801,000
962,000
1,685,000
820,000
1,297,000
1,638,000
1,949,000
1,297,000
1,416,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000001,416,0001,297,0001,949,0001,638,0001,297,000820,0001,685,000962,0001,801,0001,266,0005,835,0005,00064,000
       Short Long Term Debt 
64,000
5,000
5,835,000
1,266,000
1,801,000
962,000
1,685,000
820,000
1,297,000
1,638,000
1,949,000
1,297,000
1,416,000
1,004,000
254,000
11,000
13,000
13,000
262,000
261,000
261,000
238,000
170,000
20,000
20,000
510,000
559,000
513,000
531,000
1,085,000
1,580,000
1,652,000
1,652,0001,580,0001,085,000531,000513,000559,000510,00020,00020,000170,000238,000261,000261,000262,00013,00013,00011,000254,0001,004,0001,416,0001,297,0001,949,0001,638,0001,297,000820,0001,685,000962,0001,801,0001,266,0005,835,0005,00064,000
       Accounts payable 
2,759,000
2,674,000
376,000
371,000
530,000
404,000
403,000
453,000
349,000
498,000
524,000
512,000
542,000
605,000
408,000
452,000
513,000
615,000
689,000
674,000
794,000
696,000
732,000
803,000
862,000
868,000
899,000
929,000
942,000
921,000
906,000
907,000
907,000906,000921,000942,000929,000899,000868,000862,000803,000732,000696,000794,000674,000689,000615,000513,000452,000408,000605,000542,000512,000524,000498,000349,000453,000403,000404,000530,000371,000376,0002,674,0002,759,000
       Other Current Liabilities 
764,000
811,000
1,859,000
2,023,000
2,079,000
2,492,000
1,494,000
1,534,000
1,218,000
380,000
446,000
514,000
1,258,000
1,036,000
1,074,000
1,243,000
1,419,000
1,143,000
1,355,000
1,279,000
1,265,000
1,707,000
1,276,000
1,013,000
1,005,000
1,077,000
1,246,000
1,237,000
328,000
290,000
262,000
315,000
315,000262,000290,000328,0001,237,0001,246,0001,077,0001,005,0001,013,0001,276,0001,707,0001,265,0001,279,0001,355,0001,143,0001,419,0001,243,0001,074,0001,036,0001,258,000514,000446,000380,0001,218,0001,534,0001,494,0002,492,0002,079,0002,023,0001,859,000811,000764,000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
10,090,000
10,034,000
12,803,000
11,822,000
12,333,000
12,099,000
11,979,000
11,770,000
11,788,000
11,153,000
11,393,000
11,333,000
11,327,000
11,055,000
10,758,000
11,093,000
10,700,000
10,554,000
10,335,000
10,673,000
11,585,000
10,923,000
11,212,000
11,212,00010,923,00011,585,00010,673,00010,335,00010,554,00010,700,00011,093,00010,758,00011,055,00011,327,00011,333,00011,393,00011,153,00011,788,00011,770,00011,979,00012,099,00012,333,00011,822,00012,803,00010,034,00010,090,000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
6,000
6,000
6,000
282,000
276,000
269,000
6,000
408,000
359,000
365,000
383,000
395,000
384,000
362,000
355,000
352,000
365,000
406,000
404,000
395,000
386,000
369,000
377,000
377,000369,000386,000395,000404,000406,000365,000352,000355,000362,000384,000395,000383,000365,000359,000408,0006,000269,000276,000282,0006,0006,0006,000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
904,000
916,000
1,227,000
1,166,000
833,000
852,000
2,131,000
870,000
1,155,000
814,000
889,000
631,000
598,000
563,000
514,000
589,000
518,000
530,000
509,000
625,000
513,000
630,000
652,000
652,000630,000513,000625,000509,000530,000518,000589,000514,000563,000598,000631,000889,000814,0001,155,000870,0002,131,000852,000833,0001,166,0001,227,000916,000904,000000000000
       Deferred Long Term Liability 
18,000
19,000
58,000
66,000
191,000
128,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000128,000191,00066,00058,00019,00018,000
> Total Stockholder Equity
6,733,000
7,053,000
7,235,000
7,588,000
7,012,000
7,030,000
7,744,000
8,289,000
8,726,000
9,233,000
9,425,000
9,698,000
13,877,000
13,804,000
15,616,000
15,564,000
15,327,000
15,720,000
15,942,000
16,461,000
16,623,000
16,735,000
17,252,000
17,641,000
17,574,000
17,850,000
18,226,000
18,885,000
19,281,000
19,925,000
20,372,000
20,708,000
20,708,00020,372,00019,925,00019,281,00018,885,00018,226,00017,850,00017,574,00017,641,00017,252,00016,735,00016,623,00016,461,00015,942,00015,720,00015,327,00015,564,00015,616,00013,804,00013,877,0009,698,0009,425,0009,233,0008,726,0008,289,0007,744,0007,030,0007,012,0007,588,0007,235,0007,053,0006,733,000
   Common Stock
16,000
16,000
16,000
16,000
16,000
16,000
16,000
16,000
16,000
16,000
16,000
16,000
16,000
16,000
17,000
17,000
17,000
17,000
17,000
17,000
17,000
17,000
17,000
17,000
17,000
17,000
17,000
17,000
0
0
0
0
000017,00017,00017,00017,00017,00017,00017,00017,00017,00017,00017,00017,00017,00017,00016,00016,00016,00016,00016,00016,00016,00016,00016,00016,00016,00016,00016,00016,000
   Retained Earnings Total Equity00000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
1,000
-46,000
-53,000
-51,000
-58,000
-127,000
-16,000
25,000
34,000
88,000
79,000
139,000
270,000
168,000
131,000
151,000
206,000
253,000
237,000
239,000
262,000
222,000
432,000
531,000
268,000
178,000
208,000
232,000
0
0
0
0
0000232,000208,000178,000268,000531,000432,000222,000262,000239,000237,000253,000206,000151,000131,000168,000270,000139,00079,00088,00034,00025,000-16,000-127,000-58,000-51,000-53,000-46,0001,000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue14,240,000
Cost of Revenue-4,345,000
Gross Profit9,895,0009,895,000
 
Operating Income (+$)
Gross Profit9,895,000
Operating Expense-11,823,000
Operating Income2,417,000-1,928,000
 
Operating Expense (+$)
Research Development1,414,000
Selling General Administrative5,190,000
Selling And Marketing Expenses-
Operating Expense11,823,0006,604,000
 
Net Interest Income (+$)
Interest Income22,000
Interest Expense-265,000
Other Finance Cost-0
Net Interest Income-243,000
 
Pretax Income (+$)
Operating Income2,417,000
Net Interest Income-243,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,985,0002,605,000
EBIT - interestExpense = -265,000
1,593,000
1,858,000
Interest Expense265,000
Earnings Before Interest and Taxes (EBIT)-2,250,000
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,985,000
Tax Provision-393,000
Net Income From Continuing Ops1,592,0001,592,000
Net Income1,593,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-188,000243,000
 

Technical Analysis of Boston Scientific Corporation
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Boston Scientific Corporation. The general trend of Boston Scientific Corporation is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Boston Scientific Corporation's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Boston Scientific Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 84.00 > 84.00 > 84.00.

Tweet this
Boston Scientific Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Boston Scientific Corporation. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Boston Scientific Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Boston Scientific Corporation.

Boston Scientific Corporation Daily Moving Average Convergence/Divergence (MACD) ChartBoston Scientific Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Boston Scientific Corporation. The current adx is .

Boston Scientific Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Boston Scientific Corporation.

Boston Scientific Corporation Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Boston Scientific Corporation.

Boston Scientific Corporation Daily Relative Strength Index (RSI) ChartBoston Scientific Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Boston Scientific Corporation.

Boston Scientific Corporation Daily Stochastic Oscillator ChartBoston Scientific Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Boston Scientific Corporation.

Boston Scientific Corporation Daily Commodity Channel Index (CCI) ChartBoston Scientific Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Boston Scientific Corporation.

Boston Scientific Corporation Daily Chande Momentum Oscillator (CMO) ChartBoston Scientific Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Boston Scientific Corporation.

Boston Scientific Corporation Daily Williams %R ChartBoston Scientific Corporation Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Boston Scientific Corporation.

Boston Scientific Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Boston Scientific Corporation.

Boston Scientific Corporation Daily Average True Range (ATR) ChartBoston Scientific Corporation Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Boston Scientific Corporation.

Boston Scientific Corporation Daily On-Balance Volume (OBV) ChartBoston Scientific Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Boston Scientific Corporation.

Boston Scientific Corporation Daily Money Flow Index (MFI) ChartBoston Scientific Corporation Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Boston Scientific Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-16 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-17 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-27 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-02 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-03 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-16 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-24 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-25 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-06 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-08 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-11 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-19 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-27 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-28 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-29 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-09 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-12 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-13 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-19 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-23 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-27 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-06 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-14 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-01-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-16 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-21 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-22 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Boston Scientific Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Boston Scientific Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose98.000
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Boston Scientific Corporation with someone you think should read this too:
  • Are you bullish or bearish on Boston Scientific Corporation? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Boston Scientific Corporation? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Boston Scientific Corporation

I send you an email if I find something interesting about Boston Scientific Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about Boston Scientific Corporation.

Receive notifications about Boston Scientific Corporation in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.